| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDT | Common Stock | Award | $100K | +115K | +230.19% | $0.87 | 165K | Apr 16, 2025 | Direct |
Faith L. Charles is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Effective as of April 16, 2025, Faith Charles (the "Reporting Person") resigned from her position as a member of the Board of Directors of Conduit Pharmaceuticals Inc (the "Issuer"). As a result, the Reporting Person is no longer subject to Section 16 in connection with her transactions in equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.